SKI Market

Indian Indices

Sensex

82,626.76 -1,048.16
( -1.25%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Brooks Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533543

INE650L01011

40.7226255

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BROOKS

34.03

223.55

EPS(TTM)

Face Value()

Div & Yield %

2.23

Back

Kesoram Industries reports consolidated net profit of Rs 6.02 crore in the December 2025 quarter

Jan 16,2026

Net profit of Kesoram Industries reported to Rs 6.02 crore in the quarter ended December 2025 as against net loss of Rs 69.17 crore during the previous quarter ended December 2024. Sales declined 1.07% to Rs 64.79 crore in the quarter ended December 2025 as against Rs 65.49 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	64.79	65.49	-1
OPM %	-24.77	-9.48	-
PBDT	11.12	-12.28	LP
PBT	6.02	-18.45	LP
NP	6.02	-69.17	LP

82,626.76 -1,048.16 ( -1.25%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

57,040.53 -599.31 (-1.04%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)